Experienced healthcare development advisor Archbold to lead product strategy at Doctorlink as part of series of new hires
Doctorlink, the UK’s leading online health and symptom assessment platform for 10 million NHS patients, has appointed Neal Archbold as VP of Product.
Archbold’s appointment is part of the company’s wider mission to build on the success in the NHS by taking the Doctorlink platform global to public and private healthcare providers around the world.
An experienced strategist and healthcare business development advisor, Neal will lead product strategy and roadmap at the company as Head of the newly defined Product and Design Team.
He brings to Doctorlink more than 20 years senior management experience in healthcare, financial services and technology markets, having previously worked with some of the largest UK and global brands, including Aviva, Grant Thornton, and O2. He also co-founded SaaS health-tech company, Nuddge, which provides businesses with an employee emotional wellbeing solution.
Archbold said: “The medical profession is increasingly turning to technology to save costs, improve efficiencies and increase accessibility to healthcare, and Doctorlink is spearheading this transition.”
“I’m honoured to be part of a company generating such tangible improvements for patients and look forward to aiding its international expansion by driving their new developments in my new role.”
Archbold’s appointment marks the latest in a line of hires at Doctorlink including Product Manager Kate Morgan, Josh Akinsola, Junior Product Manager and Camilla Worthington, Project Support Coordinator. Its engineering team has also been bolstered with the hires of Annio Cavuoto, Principal Engineer, Rafael Herscovici, Senior Developer, and Shaun Gaisie, Developer.
Rupert Spiegelberg, CEO of Doctorlink, commented: “We are delighted to welcome someone of Neal’s calibre to the team. Our Symptom Assessment product has been proven to reduce the demand on NHS GPs by more than 20% as well as take pressure off A&E departments. We want to bring that transformation to patients and providers across the world, and all of our new hires will help us as we strive to reach this goal.”
Doctorlink’s Symptom Assessment tool, developed over 18 years by a team of expert clinicians, is classified as a Class 1 Medical Equipment device by the Medicines and Healthcare products Regulatory Agency. Its outcomes are sufficiently accurate to be fully indemnified, enabling the technology to be selected by one of the world’s most trusted health services – the NHS, servicing 10 million NHS patients across 1,350 GP practices.
Doctorlink has been nominated to the Financial Times’ Sifted “Top UK Startups to Follow in 2020” list.
Read the press release in The Pharma Times here